Recent advances in nanocarrier-based mucosal delivery of biomolecules

Journal of Controlled Release

Volumn 161, Issue 3, 2012, Pages 781-794

  Kammona, Olga ^b   Kiparissides, Costas ^a,b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Centre for Research Technology Hellas   (Greece)

Author keywords

Macromolecular drugs; Mucosal delivery; Mucosal vaccination; Nanocarriers

Indexed keywords

BIOLOGICAL MEDIA; BIOPHARMACEUTICAL INDUSTRY; DRUG DELIVERY SYSTEM; FUNCTIONALIZED; MACROMOLECULAR DRUGS; MICROCARRIERS; MUCOADHESIVE PROPERTIES; MUCOSAL DELIVERY; MUCOSAL SURFACE; MUCOSAL VACCINATION; NANOCARRIERS; PHYSICOCHEMICAL PROPERTY; TARGET SITES;

BIOCHEMISTRY; BIOLOGICAL MEMBRANES; BIOMOLECULES; CYTOLOGY; DRUG DELIVERY; MACROMOLECULES;

ENZYME INHIBITION;

AERX; AIR INSULIN; ALGINIC ACID; ANTHRAX VACCINE; ANTIGEN; BIOLOGICAL PRODUCT; BUSERELIN; BUSERELIN ACETATE; CHITOSAN; CHOLERA VACCINE; DESMOPRESSIN; DEXTRAN SULFATE; DRUG CARRIER; EUDRAGIT; GLUCAGON LIKE PEPTIDE 1; GONADORELIN; HEPATITIS B VACCINE; HERPES VACCINE; HYDROXYPROPYLMETHYLCELLULOSE; INFLUENZA VACCINE; INSULIN; NANOCARRIER; ORAL POLIOMYELITIS VACCINE; PHOSPHATIDYLCHOLINE; POLYACRYLIC ACID; POLYCAPROLACTONE; POLYLACTIC ACID; PROMAXX; RECOMBINANT HUMAN INSULIN; SALCATONIN; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; SHIGELLA VACCINE; SPERMINE; TECHNOSPHERE INSULIN SYSTEM; TYPHUS VACCINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BIOCOMPATIBILITY; BIODEGRADABILITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG INDUSTRY; DRUG STABILITY; DRUG STRUCTURE; HUMAN; MACROMOLECULE; NANOEMULSION; NANOPHARMACEUTICS; NONHUMAN; PHARMACODYNAMICS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; VACCINE PRODUCTION;

ANIMALS; ANTIGENS; DRUG CARRIERS; HUMANS; MUCOUS MEMBRANE; NANOPARTICLES; PEPTIDES; PROTEINS; VACCINES;

EID: 84864606285     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.05.040     Document Type: Review

References (142)

1. H. He, W. Dong, J. Gong, J. Wang, and V.C. Yang Developing macromolecular therapeutics: the future drug of choice Front. Chem. Eng. Chin. 4 1 2010 10 17
2. C. Kiparissides, and O. Kammona Nanotechnology advances in controlled drug delivery systems Phys. Status Solidi C 5 12 2008 3828 3833
3. Z. Antosova, M. Mackova, V. Kral, and T. Macek Therapeutic application of peptides and proteins: parenteral forever? Trends Biotechnol. 27 11 2009 628 635
4. R. Singh, S. Singh, and J.W. Lillard Past, present, and future technologies for oral delivery of therapeutic proteins J. Pharm. Sci. 97 7 2008 2497 2523
5. A. Sood, and R. Panchagnula Peroral route: an opportunity for protein and peptide drug delivery Chem. Rev. 101 2001 3275 3303 (Pubitemid 35373038)
6. M.-C. Chen, K. Sonaje, K.-J. Chen, and H.-W. Sung A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery Biomaterials 32 2011 9826 9838
7. J.S. Patton Mechanisms of macromolecule absorption by the lungs Adv. Drug Deliv. Rev. 19 1996 3 36 (Pubitemid 26167852)
8. H.M. Mansour, Y.-S. Rhee, and X. Wu Nanomedicine in pulmonary delivery Int. J. Nanomed. 4 2009 299 319
9. S.-A. Cryan Carrier-based strategies for targeting protein and peptide drugs to the lungs AAPS J. 7 1 2005 E20 E41
10. NanoBioPharmaceutics, Pulmonary Delivery: Assessment Report, CPERI/CERTH, 21.03.2008 (unpublished data).
11. M.I. Ugwoke, R.M. Agu, N. Verbeke, and R. Kinget Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives Adv. Drug Deliv. Rev. 57 2005 1640 1665 (Pubitemid 41443473)
12. H.R. Costantino, L. Illum, G. Brandt, P.H. Johnson, and S.C. Quay Intranasal delivery: physicochemical and therapeutic aspects Int. J. Pharm. 337 2007 1 24 (Pubitemid 46756063)
13. P. Shakya, N.V.S. Madhav, A.K. Shakya, and K. Singh Palatal mucosa as a route for systemic drug delivery: a review J. Control. Release 151 2011 2 9
14. S. Chadwick, C. Kriegel, and M. Amiji Nanotechnology solutions for mucosal immunization Adv. Drug Deliv. Rev. 62 2010 397 407
15. E.A. McNeela, and K.H.G. Mills Manipulating the immune system: humoral versus cell-mediated immunity Adv. Drug Deliv. Rev. 51 2001 43 54 (Pubitemid 32763071)
16. L.B. Lawson, E.B. Norton, and J.D. Clements Defending the mucosa: adjuvant and carrier formulations for mucosal immunity Curr. Opin. Immunol. 23 2011 414 420
17. W. Chen, G.B. Patel, H. Yan, and J. Zhang Recent advances in the development of novel mucosal adjuvants and antigen delivery systems Hum. Vaccin. 6 9 2010 706 714
18. A. Des Rieux, V. Fievez, M. Garinot, Y.-J. Schneider, and V. Preat Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach, J. Control. Release 116 2006 1 27 (Pubitemid 44792295)
19. N. Csaba, M. Garcia-Fuentes, and M.J. Alonso Nanoparticles for nasal vaccination Adv. Drug Deliv. Rev. 61 2009 140 157
20. J. Holmgren, and C. Czerkinsky Mucosal immunity and vaccines Nat. Med. Suppl. 11 4 2005 545 553
21. B. Slütter, N. Hagenaars, and W. Jiskoot Rational design of nasal vaccines J. Drug Target. 16 1 2008 1 17
22. S. Sharma, T.K.S. Mukkur, H.A.E. Benson, and Y. Chen Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems J. Pharm. Sci. 98 3 2009 812 843
23. M. Köping-Höggard, A. Sánchez, and M.J. Alonso Nanoparticles as carriers for nasal vaccine delivery Expert Rev. Vaccin. 4 2 2005 185 196 (Pubitemid 40525060)
24. N.A. Peppas, J. Brock Thomas, and J. McGinty Molecular aspects of mucoadhesive carrier development for drug delivery and improved absorption J. Biomater. Sci. 20 2009 1 20
25. L. Serra, J. Doménech, and N.A. Peppas Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents Eur. J. Pharm. Biopharm. 71 2009 519 528
26. S. Dünnhaupt, J. Barthelmes, J. Hombach, D. Sakloetsakun, V. Arkhipova, and A. Bernkop-Schnürch Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa Int. J. Pharm. 408 2011 191 199
27. D. Sakloetsakun, G. Perera, J. Hombach, G. Millotti, and A. Bernkop-Schnürch The impact of vehicles on the mucoadhesive properties of orally administrated nanoparticles: a case study with chitosan-4- thiobutylamidine conjugate AAPS PharmSciTech 11 3 2010 1185 1192
28. A. Bernkop-Schnürch, M. Hornof, and D. Guggi Thiolated chitosans Eur. J. Pharm. Biopharm. 57 2004 9 17 (Pubitemid 38058800)
29. A. Bernkop-Schnürch, A. Weithaler, K. Albrecht, and A. Greimel Thiomers: preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system Int. J. Pharm. 317 2006 76 81 (Pubitemid 43866341)
30. M. Greindl, and A. Bernkop-Schnurch Development of a novel method for the preparation of thiolated polyacrylic acid nanoparticles Pharm. Res. 23 9 2006 2183 2189
31. A. Bernkop-Schnürch Thiomers: a new generation of mucoadhesive polymers Adv. Drug Deliv. Rev. 57 2005 1569 1582 (Pubitemid 41443470)
32. Y. Ozsoy, S. Gungor, and E. Cevher Nasal delivery of high molecular weight drugs Molecules 14 2009 3754 3779
33. N.R. Labiris, and M.B. Dolovich Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications Clin. Pharmacol. 56 2003 588 599 (Pubitemid 37491710)
34. M. Shakweh, G. Ponchel, and E. Fatal Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery Expert Opin. Drug. Deliv. 1 1 2004 141 163 (Pubitemid 40297962)
35. L. Illum Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems? J. Pharm. Sci. 96 3 2007 473 483 (Pubitemid 46466073)
36. S. Hamdy, P. Elamanchili, A. Alshamsan, O. Molavi, T. Satou, and J. Samuel Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D, L-lactic-co-glycolic acid) nanoparticles J. Biomed. Mater. Res. A 81A 3 2007 652 662 (Pubitemid 46786896)
37. K. Fujihashi, and H. Kiyono Mucosal immunosenescence: new developments and vaccines to control infectious diseases Trends Immunol. 30 7 2009 334 343
38. O. Kammona, A.H. Alexopoulos, P. Karakosta, K. Kotti, V. Karageorgiou, and C. Kiparissides Nanocarrier aided nasal vaccination: an experimental and computational approach Ind. Eng. Chem. Res. 50 2011 590 601
39. A. Makhlof, Y. Tozuka, and H. Takeuchi Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery Eur. J. Pharm. Sci. 42 2011 445 451
40. F. Zheng, X.-W. Shi, G.-F. Yang, L.-L. Gong, H.-Y. Yuan, Y.-J. Cui, Y. Wang, Y.-M. Du, and Y. Li Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study Life Sci. 80 2007 388 396 (Pubitemid 44958716)
41. B. Sarmento, A. Ribeiro, F. Veiga, and D. Ferreira Development and characterization of new insulin containing polysaccharide nanoparticles Colloids Surf., B 53 2006 193 202 (Pubitemid 44802985)
42. B. Sarmento, A. Ribeiro, F. Veiga, D. Ferreira, and R. Neufeld Oral bioavailability of insulin contained in polysaccharide nanoparticles Biomacromolecules 8 2007 3054 3060 (Pubitemid 350011625)
43. M.-G. Li, W.-L. Lu, J.-C. Wang, X. Zhang, X.-Q. Wang, A.-P. Zheng, and Q. Zhang Distribution, transition, adhesion and release of insulin loaded nanoparticles in the gut of rats Int. J. Pharm. 329 2007 182 191 (Pubitemid 44937530)
44. A. Hafner, J. Lovrić, D. Voinovich, and H. Filipović- Grčić Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers Int. J. Pharm. 381 2009 205 213
45. B. Sarmento, D.C. Ferreira, L. Jorgensen, and M. Van de Weert Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles Eur. J. Pharm. Biopharm. 65 2007 10 17 (Pubitemid 44827699)
46. B. Sarmento, A. Ribeiro, F. Veiga, P. Sampaio, R. Neufeld, and D. Ferreira Alginate/chitosan nanoparticles are effective for oral insulin delivery Pharm. Res. 24 12 2007 2198 2206 (Pubitemid 350060707)
47. M.R. Rekha, and C.P. Sharma Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption J. Control. Release 135 2009 144 151
48. L. Yin, J. Ding, C. He, L. Cui, C. Tang, and C. Yin Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery Biomaterials 30 2009 5691 5700
49. J. Chen, B. Tian, X. Yin, Y. Zhang, D. Hu, Z. Hu, M. Liu, Y. Pan, J. Zhao, H. Li, C. Hou, J. Wang, and Y. Zhang Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems J. Biotechnol. 130 2007 107 113 (Pubitemid 46802857)
50. M. Simon, I. Behrens, L.A. Dailey, M. Wittmar, and T. Kissel Nanosized insulin-complexes based on biodegradable amine-modified graft polyesters poly[inyl-3-(diethylamino) propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft-poly-(L-lactic acid): protection against enzymatic degradation, interaction with Caco-2 cell monolayers, peptide transport and cytotoxicity Eur. J. Pharm. Biopharm. 66 2007 165 172 (Pubitemid 46654770)
51. P.S. Kumar, T.R. Saini, D. Chandrasekar, V.K. Yellepeddi, S. Ramakrishna, and P.V. Diwan Novel approach for delivery of insulin loaded poly(lactide-co-glycolide) nanoparticles using a combination of stabilizers Drug Deliv. 14 2007 517 523 (Pubitemid 350135853)
52. F.-D. Cui, A.-J. Tao, D.-M. Cun, L.-Q. Zhang, and K. Shi Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery J. Pharm. Sci. 96 2 2007 421 427 (Pubitemid 46363571)
53. F. Cui, K. Shi, L. Zhang, A. Tao, and Y. Kawashima Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation J. Control. Release 114 2006 242 250 (Pubitemid 44291843)
54. K. Shi, F. Cui, H. Yamamoto, and Y. Kawashima Optimized formulation of high-payload PLGA nanoparticles containing insulin-lauryl sulfate complex Drug Dev. Ind. Pharm. 35 2009 177 184
55. K. Tahara, S. Samura, K. Tsuji, H. Yamamoto, Y. Tsukada, Y. Bando, H. Tsujimoto, R. Morishita, and Y. Kawashima Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D, L-lactide-co-glycolide) nanospheres for inflammatory bowel disease Biomaterials 32 2011 870 878
56. Y.S. Yin, D.W. Chen, M.X. Qiao, Z. Lu, and H.Y. Hu Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin J. Control. Release 116 2006 337 345 (Pubitemid 44827411)
57. Y.S. Yin, D.W. Chen, M.X. Qiao, X.Y. Wei, and H.Y. Hu Lectin-conjugated PLGA nanoparticles loaded with thymopentin: ex vivo bioadhesion and in vivo biodistribution J. Control. Release 123 2007 27 38
58. P.C. Naha, V. Kanchan, P.K. Manna, and A.K. Panda Improved bioavailability of orally delivered insulin using Eudragit-L30D coated PLGA microparticles J. Microencapsul. 25 4 2008 248 256 (Pubitemid 351935682)
59. A. Des Rieux, V. Fievez, M. Momtaz, C. Detrembleur, M. Alonso-Sande, J. Van Gelder, A. Cauvin, Y.-J. Schneider, and V. Préat Helodermin-loaded nanoparticles: characterization and transport across an in vitro model of the follicle-associated epithelium J. Control. Release 118 2007 294 302 (Pubitemid 46442879)
60. T. Akagi, M. Baba, and M. Akashi Preparation of nanoparticles by the self-organization of polymers consisting of hydrophobic and hydrophilic segments: potential applications Polymer 48 2007 6729 6747 (Pubitemid 47616262)
61. C. Damgé, P. Maincent, and N. Ulrich Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats J. Control. Release 117 2007 163 170 (Pubitemid 46161872)
62. L. Jabr-Milane, L. van Vlerken, H. Devalapally, D. Shenoy, S. Komareddy, M. Bhavsar, and M. Amiji Multi-functional nanocarriers for targeted delivery of drugs and genes J. Control. Release 130 2008 121 128
63. A. Makhlof, M. Werle, Y. Tozuka, and H. Takeuchi A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa J. Control. Release 149 2011 81 88
64. N.J. Kavimandan, E. Losi, and N.A. Peppas Novel delivery system based on complexation hydrogels as delivery vehicles for insulin-transferrin conjugates Biomaterials 27 2006 3846 3854
65. S. Sajeesh, and C.P. Sharma Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery Int. J. Pharm. 325 2006 147 154 (Pubitemid 44573692)
66. M.S. Mesiha, M.B. Sidhom, and B. Fasipe Oral and subcutaneous absorption of insulin poly(isobutylcyanoacrylate) nanoparticles Int. J. Pharm. 288 2005 289 293 (Pubitemid 40038582)
67. M. Garcia-Fuentes, D. Torres, and M. José Alonso New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin Int. J. Pharm. 296 2005 122 132 (Pubitemid 40693381)
68. N. Zhang, Q. Ping, G. Huang, W. Hu, Y. Cheng, and X. Han Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin Int. J. Pharm. 327 2006 153 159 (Pubitemid 44667334)
69. S. Venkata Ramana Rao, Development of a self-nanoemulsifying drug delivery system for oral delivery of β-Lactamase, PhD Dissertation, St. John's University, Jamaica, New York, 2008.
70. S.V.R. Rao, and J. Shao Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs I. Formulation development Int. J. Pharm. 362 2008 2 9
71. S.V.R. Rao, P. Agarwal, and J. Shao Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs II. In vitro transport study Int. J. Pharm. 362 2008 10 15
72. S.V.R. Rao, K. Yajurvedi, and J. Shao Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs III. In vivo oral absorption study Int. J. Pharm. 362 2008 16 19
73. 10 Eur. J. Pharm. Sci. 39 2010 224 232
74. J. Ruan, J. Liu, D. Zhua, T. Gong, F. Yang, X. Hao, and Z. Zhang Preparation and evaluation of self-nanoemulsified drug delivery systems (SNEDDSs) of matrine based on drug-phospholipid complex technique Int. J. Pharm. 386 2010 282 290
75. X. Qi, L. Wang, J. Zhu, Z. Hu, and J. Zhang Self-double-emulsifying drug delivery system (SDEDDS): a new way for oral delivery of drugs with high solubility and low permeability Int. J. Pharm. 409 2011 245 251
76. F.M. Goycoolea, G. Lollo, C. Remuñán-López, F. Quaglia, and M.J. Alonso Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules Biomacromolecules 10 2009 1736 1743
77. K.A. Howard, U.L. Rahbek, X. Liu, C.K. Damgaard, S.Z. Glud, M.Ø. Andersen, M.B. Hovgaard, A. Schmitz, J.R. Nyengaard, F. Basenbacher, and J. Kjems RNA interference in vitro and in vivo using a chitosan/siRNA nanoparticle system Mol. Ther. 14 4 2006 476 484 (Pubitemid 44296092)
78. X. Wang, C. Zheng, Z. Wu, D. Teng, X. Zhang, Z. Wang, and C. Li Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin J. Biomed. Mater. Res. Part B 88B 2009 150 161
79. D. Teijeiro-Osorio, C. Remuñán-López, and M.J. Alonso New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules Biomacromolecules 10 2009 243 249
80. A.H. Krauland, and M.J. Alonso Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system Int. J. Pharm. 340 2007 134 142 (Pubitemid 47043346)
81. A.K. Jain, R.K. Khar, F.J. Ahmed, and P.V. Diwan Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier Eur. J. Pharm. Biopharm. 69 2008 426 435
82. S. Sundaram, S.K. Roy, B.K. Ambati, and U.B. Kompella Surface-functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium FASEB J. 23 2009 3752 3765
83. A. Grenha, C. Remuñán-López, E.L.S. Carvalho, and B. Seijo Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins Eur. J. Pharm. Biopharm. 69 2008 83 93
84. M. Amidi, H.C. Pellikaan, A.H. de Boer, D.J.A. Crommelin, W.E. Hennink, and W. Jiskoot Preparation and physicochemical characterization of supercritically dried insulin-loaded microparticles for pulmonary delivery Eur. J. Pharm. Biopharm. 68 2008 191 200
85. J. Nguyen, R. Reul, T. Betz, E. Dayyoub, T. Schmehl, T. Gessler, U. Bakowsky, W. Seeger, and T. Kissel Nanocomposites of lung surfactant and biodegradable cationic nanoparticles improve transfection efficiency to lung cells J. Control. Release 140 2009 47 54
86. K. Wernig, M. Griesbacher, F. Andreae, F. Hajos, J. Wagner, W. Mosgoeller, and A. Zimmer Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles J. Control. Release 130 2008 192 198
87. F. Hajos, B. Stark, S. Hensler, R. Prassl, and W. Mosgoeller Inhalable liposomal formulation for vasoactive intestinal peptide Int. J. Pharm. 357 2008 286 294
88. B. Stark, P. Debbage, F. Andreae, W. Mosgoeller, and R. Prassl Association of vasoactive intestinal peptide with polymer-grafted liposomes: structural aspects for pulmonary delivery Biochim. Biophys. Acta 1768 2007 705 714 (Pubitemid 46275600)
89. B. Stark, F. Andreae, W. Mosgoeller, M. Edetsberger, E. Gaubitzer, G. Koehler, and R. Prassl Liposomal vasoactive intestinal peptide for lung application: protection from proteolytic degradation Eur. J. Pharm. Biopharm. 70 2008 153 164
90. J. Liu, T. Gong, H. Fu, C. Wang, X. Wang, Q. Chen, Q. Zhang, Q. He, and Z. Zhang Solid lipid nanoparticles for pulmonary delivery of insulin Int. J. Pharm. 356 2008 333 344
91. Y. Fujimura, T. Akisada, T. Harada, and K. Haruma Uptake of microparticles into the epithelium of human nasopharyngeal lymphoid tissue Med. Mol. Morphol. 39 2006 181 186 (Pubitemid 46013055)
92. B.C. Baudner, J.C. Verhoef, M.M. Giuliani, S. Peppoloni, R. Rappuoli, G. Del Giudice, and H.E. Junginger Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform J. Drug Target. 13 2005 489 498 (Pubitemid 43347846)
93. T. Nagamoto, Y. Hattori, K. Takayama, and Y. Maitani Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery Pharm. Res. 21 2004 671 674 (Pubitemid 38457290)
94. B.D. Zhu, Y.Q. Qie, J.L. Wang, Y. Zhang, Q.Z. Wang, Y. Xu, and H.H. Wang Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of mycobacterium tuberculosis Eur. J. Pharm. Biopharm. 66 2007 318 326 (Pubitemid 46756229)
95. A. Vila, A. Sanchez, K. Janes, I. Behrens, T. Kissel, J.L.V. Jato, and M.J. Alonso Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice Eur. J. Pharm. Biopharm. 57 2004 123 131 (Pubitemid 38058811)
96. K. Khatri, A.K. Goyal, P.N. Gupta, N. Mishra, and S.P. Vyas Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against Hepatitis B Int. J. Pharm. 354 2008 235 241
97. M.L. Kang, S.G. Kang, H.L. Jiang, S.W. Shin, D.Y. Lee, J.M. Ahn, N. Rayamahji, I.K. Park, S.J. Shin, C.S. Cho, and H.S. Yoo In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing bordetella bronchiseptica DNT Eur. J. Pharm. Biopharm. 63 2006 215 220 (Pubitemid 43776213)
98. J.-L. Huang, Y.-X. Yin, Z.-M. Pan, G. Zhang, A.-P. Zhu, X.-F. Liu, and X.A. Jiao Intranasal immunization with chitosan/pCAGGS-flaA nanoparticles inhibits campylobacter jejuni in a white leghorn model J. Biomed. Biotechnol. 2010 8 10.1155/2010/589476 (Article ID 589476)
99. S. Mangal, D. Pawar, N.K. Garg, A.K. Jain, S.P. Vyas, D.S.V. Raman Rao, and K.S. Jaganathan Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally Vaccine 29 2011 4953 4962
100. H.L. Jiang, M.L. Kang, J.S. Quan, S.G. Kang, T. Akaike, H.S. Yoo, and C.S. Cho The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization Biomaterials 29 2008 1931 1939
101. O. Borges, A. Cordeiro-da-Silva, J. Tavares, N. Santarem, A. de Sousa, G. Borchard, and H.E. Junginger Immune response by nasal delivery of Hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles Eur. J. Pharm. Biopharm. 69 2008 405 416
102. X.Y. Li, X.Y. Kong, S.A. Shi, X.L. Zheng, G. Guo, Y.Q. Wei, and Z.Y. Qian Preparation of alginate coated chitosan microparticles for vaccine delivery BMC Biotechnol. 8 2008 (article 89)
103. M.L. Kang, H.-L. Jiang, S.G. Kang, D.D. Guo, D.Y. Lee, C.-S. Cho, and H.S. Yoo Pluronic® F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermone-crotoxin Vaccine 25 2007 4602 4610 (Pubitemid 46734533)
104. B. Sayin, S. Somavarapu, X.W. Li, M. Thanou, D. Sesardic, H.O. Alpar, and S. Senel Mono-n-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery Int. J. Pharm. 363 2008 139 148
105. M. Amidi, S.G. Romeijn, J.C. Verhoef, H.E. Junginger, L. Bungener, A. Huckriede, D.J. Crommelin, and W. Jiskoot N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model Vaccine 25 2007 144 153 (Pubitemid 44855251)
106. M. Amidi, S.G. Romeijn, G. Borchard, H.E. Junginger, W.E. Hennink, and W. Jiskoot Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system J. Control. Release 111 2006 107 116 (Pubitemid 43290000)
107. B. Sayin, S. Somavarapu, X.W. Li, D. Sesardic, S. Şenel, and O.H. Alpar TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines Eur. J. Pharm. Sci. 38 2009 362 369
108. M. Tafaghodi, S.A. Sajadi Tabassi, and M.R. Jaafari Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN Int. J. Pharm. 319 2006 37 43 (Pubitemid 44051800)
109. S.A. Sajadi Tabassi, M. Tafaghodi, and M.R. Jaafari Induction of high antitoxin titers against tetanus toxoid in rabbits by intranasal immunization with dextran microspheres Int. J. Pharm. 360 2008 12 17
110. S.J. Elvin, J.E. Eyles, K.A. Howard, E. Ravichandran, S. Somavarappu, H.O. Alpar, and E.D. Williamson Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine Vaccine 24 2006 4433 4439
111. H.F. Florindo, S. Pandit, L.M.D. Gonçalves, H.O. Alpar, and A.J. Almeida New approach on the development of a mucosal vaccine against strangles: systemic and mucosal immune responses in a mouse model Vaccine 27 2009 1230 1241
112. A.K. Jain, A.K. Goyal, P.N. Gupta, K. Khatri, N. Mishra, A. Mehta, S. Mangal, and S.P. Vyas Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against Hepatitis B J. Control. Release 136 2009 161 169
113. A. Vila, A. Sanchez, C. Evora, I. Soriano, O. McCallion, and M.J. Alonso PLA-PEG particles as nasal protein carriers: the influence of the particle size Int. J. Pharm. 292 2005 43 52 (Pubitemid 40255787)
114. H.P. Zhao, B. Wu, H. Wu, L.Y. Su, J.L. Pang, T.H. Yang, and Y.L. Liu Protective immunity in rats by intranasal immunization with Streptococcus Mutans glucan-binding protein D encapsulated into chitosan-coated poly(lactic-co- glycolic acid) microspheres Biotechnol. Lett. 28 2006 1299 1304 (Pubitemid 44078500)
115. J. Singh, S. Pandit, V.W. Bramwell, and H.O. Alpar Diphtheria toxoid loaded poly-([epsilon]-caprolactone) nanoparticles as mucosal vaccine delivery dystems Methods 38 2006 96 105 (Pubitemid 43163469)
116. N. Csaba, A. Sanchez, and M.J. Alonso PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery J. Control. Release 113 2006 164 172 (Pubitemid 43928142)
117. K.S. Jaganathan, and S.P. Vyas Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant Hepatitis B antigen administered intranasally Vaccine 24 2006 4201 4211
118. T. Akagi, X. Wang, T. Uto, M. Baba, and M. Akashi Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives Biomaterials 28 2007 3427 3436 (Pubitemid 46729729)
119. H.F. Florindo, S. Pandit, L. Lacerda, L.M.D. Goncalves, H.O. Alpar, and A.J. Almeida The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles Biomaterials 30 2009 879 891
120. R. Voltan, A. Castaldello, E. Brocca-Cofano, G. Altavilla, A. Caputo, M. Laus, K. Sparnacci, B. Ensoli, S. Spaccasassi, M. Ballestri, and L. Tondelli Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes Pharm. Res. 24 2007 1870 1882 (Pubitemid 47389242)
121. A. Stano, A.J. van der Vlies, M.M. Martino, M.A. Swartz, J.A. Hubbella, and E. Smeoni PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration Vaccine 29 2011 804 812
122. M. Tafaghodi, M.R. Jaafari, and S.A. Sajadi Tabassi Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN Eur. J. Pharm. Biopharm. 64 2006 138 145 (Pubitemid 44291992)
123. A. Joseph, N. Itskovitz-Cooper, S. Samira, O. Flasterstein, H. Eliyahu, D. Simberg, I. Goldwaser, Y. Barenholz, and E. Kedar A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice Vaccine 24 2006 3990 4006
124. K. Khatri, A.K. Goyal, P.N. Gupta, N. Mishra, A. Mehta, and S.P. Vyas Surface modified liposomes for nasal delivery of DNA vaccine Vaccine 26 2008 2225 2233
125. S. Saraf, D. Mishra, A. Asthana, R. Jain, S. Singh, and N.K. Jain Lipid microparticles for mucosal immunization against Hepatitis B Vaccine 24 2006 45 56 (Pubitemid 41722204)
126. A. Grenha, B. Seijo, C. Serra, and C. Remuñán-López Chitosan nanoparticle-loaded mannitol microspheres: structure and surface characterization Biomacromolecules 8 2007 2072 2079 (Pubitemid 47104289)
127. O. Borges, A. Cordeiro-da-Silva, S.G. Romeijn, M. Amidi, A. De Sousa, G. Borchard, and H.E. Junginger Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination J. Control. Release 114 2006 348 358 (Pubitemid 44310817)
128. B. Slütter, L. Plapied, V. Fievez, M. Alonso Sande, A. des Rieux, Y.-J. Schneider, E. Van Riet, W. Jiskoot, and V. Préat Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination J. Control. Release 138 2009 113 121
129. S. Jain, R. Kumar Sharma, and S.P. Vyas Chitosan nanoparticles encapsulated in vesicular systems for oral immunization: preparation, in-vitro and in-vivo characterization J. Pharm. Pharmacol. 58 2006 303 310 (Pubitemid 43344572)
130. F. Chen, Z.-R. Zhang, F. Yuan, X. Qin, M. Wang, and Y. Huang In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery Int. J. Pharm. 349 2008 226 233 (Pubitemid 350299699)
131. A.K. Jain, A.K. Goval, N. Mishra, B. Vaidya, S. Mangal, and S.P. Vyas PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against Hepatitis B Int. J. Pharm. 387 2010 253 262
132. F. Sarti, G. Perera, F. Hintzen, K. Kotti, V. Karageorgiou, O. Kammona, C. Kiparissides, and A. Bernkop-Schnürch In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A Biomaterials 32 2011 4052 4057
133. P.N. Gupta, S. Mahor, A. Rawat, K. Khatri, A. Goyal, and S.P. Vyas Lectin anchored stabilized biodegradable nanoparticles for oral immunization 1. Development and in vitro evaluation Int. J. Pharm. 318 2006 163 173 (Pubitemid 43963301)
134. M. Garinot, V. Fievez, V. Pourcelle, F. Stoffelbach, A. des Rieux, L. Plapied, I. Theate, H. Freichels, C. Jérôme, J. Marchand-Brynaert, Y.-J. Schneider, and V. Préat PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination J. Control. Release 120 2007 195 204 (Pubitemid 47061488)
135. H.H. Salman, C. Gamazo, P.C. de Smidt, G. Russell-Jones, and J.M. Irache Evaluation of bioadhesive capacity and immunoadjuvant properties of vitamin B12-Gantrez nanoparticles Pharm. Res. 25 12 2008 2859 2868
136. S. Misumi, M. Masuyama, N. Takamune, D. Nakayama, R. Mitsumata, H. Matsumoto, N. Urata, Y. Takahashi, A. Muneoka, T. Sukamoto, K. Fukuzaki, and S. Shoji Targeted delivery of immunogen to primate M cells with tetragalloyl lysine dendrimer J. Immunol. 182 2009 6061 6070
137. P.N. Gupta, and S.P. Vyas Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization Colloids Surf., B 82 2011 118 125
138. C. Prego, M. Garcia, D. Torres, and M.J. Alonso Transmucosal macromolecular drug delivery J. Control. Release 101 2005 151 162 (Pubitemid 39600979)
139. R.C. Mundargi, V.R. Babu, V. Rangaswamy, P. Patel, and T.M. Aminabhavi Nano/micro technologies for delivering macromolecular therapeutics using poly(D, L-lactide-co-glycolide) and its derivatives J. Control. Release 125 2008 193 209
140. F. Mohamed, and C.F. van der Walle Engineering biodegradable polyester particles with specific drug targeting and drug release properties J. Pharm. Sci. 97 1 2008 71 87
141. F. Cui, F. Qian, and C. Yin Preparation and characterization of mucoadhesive polymer-coated nanoparticles Int. J. Pharm. 316 2006 154 161 (Pubitemid 43765702)
142. M. Rawat, D. Singh, S. Saraf, and S. Saraf Lipid carriers: a versatile delivery vehicle for proteins and peptides Yakugaku Zasshi 128 2 2008 269 280 (Pubitemid 351237899)